Location: New Brunswick, NJ
CIK: 0000200406 · Show all filings
Period: Q2 2026 (← Previous) (Next →)
Filing Date: Aug 6, 2026
Total Value: $799M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,449,183 | $300M | 37.6% | $122.58 | $42.63 | +187.5% | COM | 74366E102 |
| NBTX | NANOBIOTIX | 5,623,816 | $212M | 26.5% | $37.70 | $6.67 | +465.2% | SPONSORED ADS | 63009J107 |
| MGTX | MEIRAGTX HLDGS PLC | 6,641,064 | $89.72M | 11.2% | $13.51 | $9.84 | +37.2% | COM | G59665102 |
| RAPP | RAPPORT THERAPEUTICS INC | 1,784,517 | $74.36M | 9.3% | $41.67 | $23.15 | +80.0% | COM | 75383L102 |
| CTNM | CONTINEUM THERAPEUTICS INC | 1,979,173 | $32.44M | 4.1% | $16.39 | $16.10 | +1.8% | CL A | 21217B100 |
| LEGN | LEGEND BIOTECH CORP | 814,586 | $23.53M | 2.9% | $28.88 | $41.61 | -30.6% | SPONSORED ADS | 52490G102 |
| CVRX | CVRX INC | 4,024,861 | $20.69M | 2.6% | $5.14 | $19.85 | -74.1% | COM | 126638105 |
| XNCR | XENCOR INC | 748,062 | $12.04M | 1.5% | $16.10 | $37.91 | -57.5% | COM | 98401F105 |
| CBRS | CEREBRAS SYSTEMS INC | 53,586 | $11.84M | 1.5% | $221.00 | $235.36 | -6.1% | COM CL A | 15675D103 |
| FATE | FATE THERAPEUTICS INC | 3,379,064 | $9.123M | 1.1% | $2.70 | $78.44 | -96.6% | COM | 31189P102 |
| PRCT | PROCEPT BIOROBOTICS CORP | 357,939 | $8.082M | 1.0% | $22.58 | $38.38 | -41.2% | COM | 74276L105 |
| NMRA | NEUMORA THERAPEUTICS INC. | 1,849,445 | $3.144M | 0.4% | $1.70 | $12.57 | -86.5% | COM | 640979100 |
| VOR | VOR BIOPHARMA INC | 53,732 | $989K | 0.1% | $18.41 | $18.62 | -1.1% | COM NEW | 929033207 |
| LAB | STANDARD BIOTOOLS INC | 311,967 | $257K | 0.0% | $0.82 | $2.41 | -66.0% | COM | 34385P108 |
| ACET | ADICET BIO INC | 22,779 | $197K | 0.0% | $8.64 | $11.05 | -21.8% | COM NEW | 007002207 |